New figure in UK international healthcare policy
This article was originally published in Clinica
Executive Summary
The UK's Department of Health (DH) is setting up an International Health Advisory Board to support the chief medical officer in his role as advisor to the government on international health issues. Through a network of experts, the board will be relied upon to provide independent, expert advice; it will also seek to raise the profile of the DH's international health activities. Hamid Ghodse, director of the International Centre of Drug Policy, at the University of London's St George’s college, will be its inaugural chairperson. "Many of today’s health issues need to be considered in an international context and it is essential that the UK plays a full role in the relevant international forums, both learning from the experience of others and making an effective contribution," said Professor Ghodse.
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.